000 | 02733naa a2200349uu 4500 | ||
---|---|---|---|
001 | 1051016264837 | ||
003 | OSt | ||
005 | 20240604062543.0 | ||
008 | 110510s2010 xx ||||gr |0|| 0 eng d | ||
100 | 1 |
_aFENN, Paul _944770 |
|
245 | 1 | 0 | _aEnterprise liability, risk pooling and diagnostic care |
260 |
_aCary : _bOxford University, _cjuly 2010 |
||
520 | 3 | _aThe safety of patients is an important responsability of health care providers, and significant compensation costs may arise if providers are negligent. A widely debated option involves liability for such compensation being placed with the hospital rather than the individual clinician, a system known as "enterprise liability". In the United States, partial adoption of enterprise liability and proposals for its universal introduction have accompanied high-profile "malpractice insurance crises" in the last two decades. Hospitals in England and Wales have been subject to this sytem since 1990, and risk-pooling arrangements have emerged subsequently allowing hospitals to tranfer their liability risk to an agency known as the National Health Service Litigation Authority. We explore some of the mechanisms used by this agency to provide hospital management with financial incentives to take care. We estimate the influence of these arrangements on the use of diagnostic imaging tests within shift took place leading to a form of "natural experiment". Our results suggest that the use of diagnostic tests did not respond to the incentives created during this period. We speculate that certain types of patient care activity, including the use of diagnostic tests, may be less responsive to incentives placed at the level of the hospital by comparison with incentives placed at the level of the clinician. Our findings may have implications for jurisdictions contemplating a move to enterprise liability as well as wider implications for public-sector organizations faced with financial incentives to improve service quality | |
590 | _aIncentives and Public Service Performance: a special issue | ||
590 | _aVolume 20 | ||
590 | _aSupplement 2 | ||
590 | _aJuly 2010 | ||
650 | 4 |
_912122 _aPolítica de Saúde |
|
650 | 4 |
_aControle de Qualidade _912058 |
|
650 | 4 |
_aEmpresa Privada _912915 |
|
650 | 4 |
_aRegulação _912883 |
|
650 | 4 |
_aFiscalização _912997 |
|
700 | 1 |
_aGRAY, Alastair _944771 |
|
700 | 1 |
_aRICKMAN, Neil _944772 |
|
700 | 1 |
_aVENCAPPA, Dev _944773 |
|
700 | 1 |
_aRIVERO, Oliver _944774 |
|
700 | 1 |
_aLOTTI, Emanuela _944775 |
|
773 | 0 | 8 |
_tJournal of Public Administration Research and Theory - JPART _g20, 2, p. i225-i242 _dCary : Oxford University, july 2010 _xISSN 10531858 _w |
942 | _cS | ||
998 |
_a20110510 _b1626^b _cDaiane |
||
998 |
_a20120517 _b1521^b _cGeisneer |
||
999 |
_aConvertido do Formato PHL _bPHL2MARC21 1.1 _c39422 _d39422 |
||
041 | _aeng |